Alternatives to aflibercept
1 same-class SPL records vs aflibercept - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Eylea
About aflibercept
AHZANTIVE is a medicine used to treat certain eye problems. It helps to stop blood vessels from growing and leaking in the eye.
Used for: AHZANTIVE treats wet age-related macular degeneration (AMD). It also treats swelling in the macula (the central part of the retina) caused by retinal vein occlusion (RVO) or diabetic macular edema (DME). Additionally, it can treat diabetic retinopathy (DR), an eye disease caused by diabetes.
1 Anti-VEGF (Ophthalmic Injection) peers (wide set)
aflibercept vs ranibizumab · FAERS reaction fields
FAERS top-reaction field "Death" shows the widest count spread between aflibercept and ranibizumab in this extract (4,070-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | aflibercept | ranibizumab |
|---|---|---|
| Death | 7,853 | 3,783 |
| Visual Impairment | 2,013 | 1,623 |
| Blindness | 1,459 | 1,036 |
| Endophthalmitis | 1,372 | 727 |
| Visual Acuity Reduced | 1,244 | 2,888 |
| Eye Pain | 1,181 | 954 |
| Vision Blurred | 1,161 | 1,029 |
| Blindness Unilateral | 1,068 | - |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
aflibercept peer mix vs class inventory
Peer mix
0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for Anti-VEGF (Ophthalmic Injection): 2 drugs.
Frequently Asked Questions
What same-class SPL records sit beside aflibercept? ▼
Reading a wide Anti-VEGF (Ophthalmic Injection) peer set (1 records)
aflibercept (Eylea) sits in a wide Anti-VEGF (Ophthalmic Injection) peer set (1 of 1 class peers shown). Labeled indication field for aflibercept: AHZANTIVE treats wet age-related macular degeneration (AMD).
Top FAERS reaction fields for aflibercept total 19,349 reports across 10 reactions, set beside ranibizumab. Counts are exposure-weighted submissions, not per-patient risk.
Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for aflibercept: see also the generic vs brand label guide when reading Eylea SPL strings.
Read our methodology - how this data is sourced, computed, and verified.